SANUWAVE Health, Inc.
- Jurisdiction
United States - ISIN
US80303D3052 (SNWV )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
1
/ 7
Profile
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Read full profile
Fundamentals
- Net revenue
€33.43M - Gross margin
77.7% - EBIT
€6.26M - EBIT margin
18.7% - Net income
-€32.43M - Net margin
-97.0%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Earnings Calls
Earnings Calls
Latest earnings call: May 10, 2024 (Q1 2024)